-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
AIM ImmunoTech Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- AIM ImmunoTech Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$4.49M, a 45% increase year-over-year.
- AIM ImmunoTech Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$27.9M, a 19% decline year-over-year.
- AIM ImmunoTech Inc. annual Operating Income (Loss) for 2023 was -$31.9M, a 60.2% decline from 2022.
- AIM ImmunoTech Inc. annual Operating Income (Loss) for 2022 was -$19.9M, a 5.76% decline from 2021.
- AIM ImmunoTech Inc. annual Operating Income (Loss) for 2021 was -$18.8M, a 24.3% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)